CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
59333-79-8 | 4-羥基異喹胍; 4-羥基-3,4-二氫-1H-異喹啉-2-甲脒 | 4-HydroxydeBrisoquine; 4-Hydroxy-3,4-dihydro-1H-isoquinoline-2-carboxamidine | ![]() | C10H13N3O | 詳情 | 供應商 |
143502-17-4 | D-Glucose,2-(acetylamino)-4-O-[2-(acetylamino)-2-deoxy-4-O-sulfo-b-D-galactopyranosyl]-2-deoxy-; 2-(acetylamino)-4-O-(2-(acetylamino)-2-deoxy-4-O-sulfogalactopyranosyl)-2-deoxyglucose; 3.5%NACL GLUCOSE,CLINICAL DETECTION,VIBriO DETECTION | ![]() | C16H28N2O14S | 詳情 | 供應商 | |
61302-92-9 | Dibenzo[f,h]pyrrolo[1,2-b]isoquinoline,9,11,12,13,13a,14-hexahydro-2,3,5,6-tetramethoxy-, (S)- (9CI); (-)-TylocreBrine | ![]() | C24H27NO4 | 詳情 | 供應商 | |
129285-34-3 | Olean-12-ene-3,22,29-triol,(3b,20a,22b)- (9CI); (+)-ABrisapogenolA; ABrisapogenol A | ![]() | C30H50O3 | 詳情 | 供應商 | |
121994-09-0 | Olean-13(18)-ene-3,22-diol,(3b,22b)- (9CI); (-)-ABrisapogenolG; ABrisapogenol G | ![]() | C30H50O2 | 詳情 | 供應商 | |
121994-06-7 | Olean-12-ene-3,22,23,29-tetrol,(3b,4b,20a,22b)- (9CI); (+)-ABrisapogenolB; ABrisapogenol B | ![]() | C30H50O4 | 詳情 | 供應商 | |
121994-08-9 | Olean-12-en-22-one,3-hydroxy-, (3b)-(9CI); (+)-ABrisapogenolF; ABrisapogenol F | ![]() | C30H48O2 | 詳情 | 供應商 | |
121994-07-8 | Olean-12-ene-3,22,23,29-tetrol,(3b,4b,20b,22b)- (9CI); (+)-ABrisapogenolE; ABrisapogenol E; Wistariasapogenol B | ![]() | C30H50O4 | 詳情 | 供應商 | |
148057-46-9 | 1H,3H-Furo[3,4-c]furan,1-(3,4-dimethoxyphenyl)tetrahydro-4-(4-methoxyphenyl)-, (1S,3aR,4S,6aR)-; 1H,3H-Furo[3,4-c]furan,1-(3,4-dimethoxyphenyl)tetrahydro-4-(4-methoxyphenyl)-, [1S-(1a,3aa,4a,6aa)]-; (+)-MemBrine; MemBrin | ![]() | C21H24O5 | 詳情 | 供應商 | |
22906-83-8 | 1,4-Pentanediamine,N4-(7-chloro-2-methoxybenzo[b]-1,5-naphthyridin-10-yl)-N1,N1-diethyl-; Benzo[b]-1,5-naphthyridine,7-chloro-10-[[4-(diethylamino)-1-methylbutyl]amino]-2-methoxy- (6CI,8CI); Benzo[b]-1,5-naphthyridine, 1,4-pentanediamine deriv.; 1-Aza-ateBrin; 1-Aza-ateBrine; Azamepacrine; WR 12921 | ![]() | C22H29ClN4O | 詳情 | 供應商 | |
23544-42-5 | 1H-Indol-6-ol,3a-(3,4-dimethoxyphenyl)octahydro-1-methyl-, (3aS,6R,7aS)-; 1H-Indol-6-ol,3a-(3,4-dimethoxyphenyl)octahydro-1-methyl-, [3aS-(3aa,6a,7aa)]-; 4a,9a-MesemBrine, 7-deoxo-7a-hydroxy- (8CI); (-)-Mesembranol; Mesembranol | ![]() | C17H25NO3 | 詳情 | 供應商 | |
105121-95-7 | 2(1H)-Isoquinolinecarboximidamide,3,4-dihydro-4-hydroxy-, (4R)-; 2(1H)-Isoquinolinecarboximidamide,3,4-dihydro-4-hydroxy-, (R)-; (R)-4-HydroxydeBrisoquine; R(-)-4-HydroxydeBrisoquine | ![]() | C10H13N3O | 詳情 | 供應商 | |
105121-93-5 | 2(1H)-Isoquinolinecarboximidamide,3,4-dihydro-4-hydroxy-, (4S)-; 2(1H)-Isoquinolinecarboximidamide,3,4-dihydro-4-hydroxy-, (S)-; (S)-4-HydroxydeBrisoquine; S-(+)-4-HydroxydeBrisoquine | ![]() | C10H13N3O | 詳情 | 供應商 | |
24159-07-7 | 4(3H)-Quinazolinone,3-[3-[(2R,3S)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-; FeBrifugine(7CI,8CI); (+)-FeBrifugine; Dichroin B; NSC 315535; trans-(+)-FeBrifugine; b-Dichroin; b-Dichroine | ![]() | C16H19N3O3 | 詳情 | 供應商 | |
480-39-7 | 松屬素; 松屬素; | 4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-phenyl-, (2S)-; 4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-phenyl-, (S)-; PinocemBrin (6CI); (+)-PinocemBrin; (+)-PinocoemBrin; 5,7-Dihydroxyflavanone; Dihydrochrysin; Galangin flavanone; NSC 279005 | ![]() | C15H12O4 | 詳情 | 供應商 |
36052-66-1 | 4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dimethoxy-2-phenyl-, (2S)-; 4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dimethoxy-2-phenyl-, (S)-; (2S)-5,7-Di-O-methylpinocemBrin; 5,7-Dimethoxyflavan-4-one; 5,7-Dimethoxyflavanone; O,O-DimethylpinocemBrin; PinocemBrin dimethyl ether | ![]() | C17H16O4 | 詳情 | 供應商 | |
468-53-1 | 6H-Indol-6-one,3a-(3,4-dimethoxyphenyl)octahydro-1-methyl-, (3aR,7aR)-; 6H-Indol-6-one,3a-(3,4-dimethoxyphenyl)octahydro-1-methyl-, (3aR-cis)-; MesemBrine, (+)-(8CI); (+)-MesemBrine | ![]() | C17H23NO3 | 詳情 | 供應商 | |
24880-43-1 | 6H-Indol-6-one,3a-(3,4-dimethoxyphenyl)octahydro-1-methyl-, (3aS,7aS)-; 4a,9a-MesemBrine (8CI); 6H-Indol-6-one,3a-(3,4-dimethoxyphenyl)octahydro-1-methyl-, (3aS-cis)-; (-)-Mesembranone; (-)-MesemBrine; Mesembranone; MesemBrin; MesemBrine; MesemBrine, (-)- | ![]() | C17H23NO3 | 詳情 | 供應商 | |
125093-93-8 | VIP ANTAGONIST | H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SE; H-LYS-PRO-ARG-ARG-PRO-TYR-THR-ASP-ASN-TYR-THR-ARG-LEU-ARG-LYS-GLN-MET-ALA-VAL-LYS-LYS-TYR-LEU-ASN-SER-ILE-LEU-ASN-NH2; KPRRPYTDNYTRLRKQMAVKKYLNSILN-NH2; VASOACTIVE INTESTINAL PEPTIDE ANTAGONIST; VIP ANTAGONIST; (lys1,pro2,5,arg3,4,tyr6)-vasoactive*intestinal P; (LYS1 PRO2 5 ARG3 4 TYR6)-VASOACTIVE &; (VIP-neurotensin) hyBrid antagonist; H-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | ![]() | C154H257N49O40S | 詳情 | 供應商 |
9024-60-6 | L-ORNITHINE DECARBOXYLASE FROM*ESCHERICH IA COLI; L-ORNITHINE DECARBOXYLASE FROM*ESCHERICH IA COLI; ornithinedecarboxylase; L-ornithine decarboxylase from E. coli; 3.5%NACL ORNITHINE DECARBOXYLASE,CLINICAL DETECTION,VIBriO DETECTION | 無 | 詳情 | 供應商 |